Richard W Compans

Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.

Mark R Prausnitz, Yeu-Chun Kim, M. Prausnitz, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin.

Mark R Prausnitz, James C Birchall, Yeu-Chun Kim, 2010, Vaccine.

The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial

Tianwei Yu, Mark R Prausnitz, Sebastien Henry, 2017, The Lancet.

Virus-like particles as universal influenza vaccines

Min-Chul Kim, R. Compans, Min-chul Kim, 2012, Expert review of vaccines.

Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.

Mark R Prausnitz, Yeu-Chun Kim, M. Prausnitz, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Ebola Vaccination Using a DNA Vaccine Coated on PLGA‐PLL/γPGA Nanoparticles Administered Using a Microneedle Patch

Hung-Wei Yang, Mark R Prausnitz, Xin Dong Guo, 2017, Advanced healthcare materials.